Evidence map›Paper›PMID 25384477›Full record

ArticleJournal of bacteriology2015

Pseudomonas aeruginosa LysR PA4203 regulator NmoR acts as a repressor of the PA4202 nmoA gene, encoding a nitronate monooxygenase.

Ken Vercammen, Qing Wei, Daniel Charlier, Andreas Dötsch, Susanne Haüssler, Sebastian Schulz, Francesca Salvi, Giovanni Gadda, Jim Spain, Morten Levin Rybtke and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Applied and environmental microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Ken VercammenResearch Group of Microbiology, Department of Bioengineering Sciences, Vrije Universiteit Brussel, Brussels, Belgium VIB Department of Structural Biology, Vrije Universiteit Brussel, Brussels, Belgium.
Qing WeiResearch Group of Microbiology, Department of Bioengineering Sciences, Vrije Universiteit Brussel, Brussels, Belgium VIB Department of Structural Biology, Vrije Universiteit Brussel, Brussels, Belgium.
Daniel CharlierResearch Group of Microbiology, Department of Bioengineering Sciences, Vrije Universiteit Brussel, Brussels, Belgium.
Andreas DötschChronic Pseudomonas Infection Research Group, Helmholtz Center for Infection Research, Braunschweig, and TWINCORE, Center for Experimental and Clinical Infection Research, Hanover, Germany.
Susanne HaüsslerChronic Pseudomonas Infection Research Group, Helmholtz Center for Infection Research, Braunschweig, and TWINCORE, Center for Experimental and Clinical Infection Research, Hanover, Germany.
Sebastian SchulzChronic Pseudomonas Infection Research Group, Helmholtz Center for Infection Research, Braunschweig, and TWINCORE, Center for Experimental and Clinical Infection Research, Hanover, Germany.
Francesca SalviDepartment of Chemistry, Georgia State University, Atlanta, Georgia, USA.
Giovanni GaddaDepartment of Chemistry, Georgia State University, Atlanta, Georgia, USA Department of Biology, Georgia State University, Atlanta, Georgia, USA Center for Biotechnology and Drug Design, Georgia State University, Atlanta, Georgia, USA Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia, USA.
Jim SpainSchool of Civil and Environmental Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.
Morten Levin RybtkeDepartment of International Health, Immunology, and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Tim Tolker-NielsenDepartment of International Health, Immunology, and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jozef DingemansResearch Group of Microbiology, Department of Bioengineering Sciences, Vrije Universiteit Brussel, Brussels, Belgium VIB Department of Structural Biology, Vrije Universiteit Brussel, Brussels, Belgium.
Lumeng YeResearch Group of Microbiology, Department of Bioengineering Sciences, Vrije Universiteit Brussel, Brussels, Belgium VIB Department of Structural Biology, Vrije Universiteit Brussel, Brussels, Belgium.
Pierre CornelisResearch Group of Microbiology, Department of Bioengineering Sciences, Vrije Universiteit Brussel, Brussels, Belgium VIB Department of Structural Biology, Vrije Universiteit Brussel, Brussels, Belgium pcornel@vub.ac.be.
Vrije Universiteit Brussel · BECenter for Experimental and Clinical Infection Research · DEGeorgia State University · USUniversity of Copenhagen · DKGeorgia Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The PA4203 gene encodes a LysR regulator and lies between the ppgL gene (PA4204), which encodes a periplasmic gluconolactonase, and, in the opposite orientation, the PA4202 (nmoA) gene, coding for a nitronate monooxygenase, and ddlA (PA4201), encoding a d-alanine alanine ligase. The intergenic regions between PA4203 and ppgL and between PA4203 and nmoA are very short (79 and 107 nucleotides, respectively). Here we show that PA4203 (nmoR) represses its own transcription and the expression of nmoA. A chromatin immunoprecipitation analysis showed the presence of a single NmoR binding site between nmoA and nmoR, which was confirmed by electrophoretic mobility shift assays (EMSAs) with the purified NmoR protein. Despite this observation, a transcriptome analysis revealed more genes to be affected in an nmoR mutant, including genes known to be part of the MexT LysR activator regulon. The PA1225 gene, encoding a quinone oxidoreductase, was the most highly upregulated gene in the nmoR deletion mutant, independently of MexT. Finally, deletion of the nmoA gene resulted in an increased sensitivity of the cells to 3-nitropropionic acid (3-NPA), confirming the role of the nitronate monooxygenase protein in the detoxification of nitronate.

Indexed as

Bacterial ProteinsComputer SimulationDNA, IntergenicGene DeletionGene Expression Regulation, BacterialGene Expression Regulation, EnzymologicGenome, BacterialMixed Function OxygenasesMolecular Sequence DataOligonucleotide Array Sequence AnalysisPseudomonas aeruginosaBacterial ProteinsDNA, IntergenicMixed Function Oxygenases

Identifiers

PMID25384477
PMCPMC4336338
OpenAlexW2154924544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.